Browsing Category
Pharma Industry News
4751 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Sai Life Sciences unveils cutting-edge Peptide Research Center to fuel biotech breakthroughs
Sai Life Sciences launches Peptide Research Center in Hyderabad to expand peptide therapeutics and R&D services. Learn how this impacts pharma innovation and investors.
Emcure Pharmaceuticals expands European footprint as Tillomed grabs Manx’s drug portfolio in £19.7m deal
Emcure’s Tillomed acquires Manx’s pharma portfolio in a £19.7M deal to expand in Europe—read how it affects growth, stock outlook, and investor sentiment.
Innovent’s IBI363 gains NMPA breakthrough therapy designation, boosting regulatory momentum
Innovent’s IBI363 secures NMPA breakthrough therapy designation for melanoma. Discover its clinical potential, investment outlook, and global impact.
Lilly’s lepodisiran shows 94% reduction in lipoprotein(a), offering hope for cardiovascular risk management
Lilly’s lepodisiran slashed lipoprotein(a) by 94% in a Phase 2 trial. See how this breakthrough could change cardiovascular disease treatment.
AstraZeneca to invest $2.5bn in Beijing R&D hub, biotech partnerships, and vaccine manufacturing
AstraZeneca is investing $2.5 billion in Beijing for R&D, biotech partnerships, and vaccine production. Learn how this move impacts its market strategy.
Everest Medicines gains FDA approval for EVM14 cancer vaccine, boosting mRNA oncology pipeline
Everest Medicines secures FDA approval for EVM14, its first internally developed mRNA cancer vaccine, paving the way for global clinical trials.
Clover Biopharmaceuticals receives FDA clearance for RSV vaccine trial, expands respiratory disease research
Clover Biopharmaceuticals advances RSV vaccine research with FDA-approved SCB-1019 trials, targeting revaccination gaps and combination immunization strategies.
Innovent Biologics advances IBI354 into Phase 3 trial for HER2-expressing platinum-resistant ovarian cancer
Discover how Innovent Biologics is advancing IBI354, a novel HER2-targeted therapy, into Phase 3 trials to transform ovarian cancer treatment.
CStone targets European expansion with EMA filing for Sugemalimab in stage III NSCLC
CStone Pharmaceuticals seeks EMA approval for sugemalimab in stage III NSCLC, aiming to expand lung cancer immunotherapy options in Europe.
Taiho Pharmaceutical to expand ADC portfolio with Araris Biotech acquisition
Taiho Pharmaceutical is acquiring Araris Biotech for $1.14 billion, strengthening its ADC oncology pipeline. Discover how this deal is shaping the future of cancer treatment.